May your reconstitutions stay clear, your calculations stay accurate, and your protocols stay consistent.
The advantages go even further
How does dopamine impact motivation, according to Huberman
A study in rats found that BPC 157 counteracted the effects of an induced myocardial injury and significantly decreased oxidative stress
Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
Despite marketing claims, no published clinical data demonstrates that any compounded oral tirzepatide formulation achieves bioavailability comparable to injection
